News & Articles

Guest editorial by Dale Powner, Country Manager for the UK, Ireland and Nordics at Binding Site, part of Thermo Fisher Scientific

With antimicrobial resistance on the rise, rapid AST offers a lifeline for critically ill patients and supports improved antibiotic stewardship

Molecular diagnostics experts share why EQCs are no longer optional if you’re looking to elevate your molecular diagnostics

One lab shares its experience boosting efficiency and accuracy with StatLab’s PiSmart Cassette and Slide printers

One lab shares its experience switching to Streck’s quality control solution for molecular diagnostics testing

Oncomine Dx Target Test approved to identify patients eligible for HERNEXEOS (zongertinib tablets), the first and only orally administered targeted treatment for HER2 (ERBB2)-mutant NSCLC

Enabling accurate and accessible ethyl alcohol testing across moderate complexity laboratories

Initiative to expand testing access to underserved U.S. communities

Revvity’s Euroimmun shares insights on the role of amyloid-beta, tau, neurofilament and APOE genotype in Alzheimer’s disease diagnostics

A focused clinical approach to second-generation anti-seizure medications and laboratory diagnostics

Cleanroom microbiology expert, Cherwell, to become AnalytiChem UK Ltd from 1st September 2025

Understaffing in the lab threatens the collaboration doctors depend on

AliveDx has received IVDR-CE Mark for its multiplexed MosaiQ AiPlex Vasculitis (VAS) assay, designed to speed diagnosis of ANCA-associated vasculitides and Anti-GBM (Goodpasture’s) disease

46 companies and organizations were honored for supporting the association through advertising, sponsorships, and exhibits

First-of-its-kind study at ADLM 2025 lays the foundation for addressing public health threat

From concept to clinic, NExT gives researchers and developers access to Fujirebio’s unmatched expertise in neurological biomarker testing

New findings at ADLM 2025 could remedy this failure

Dr. Stanley F. Lo, DABCC, FADLM, has been elected to serve on the ADLM board of directors as president-elect starting in August 2025

The award recognises Gradientech’s impactful and innovative campaign to raise awareness about its QuickMIC ultra-rapid antibiotic susceptibility testing (AST) system

With a bold new identity and expanded capabilities, HiArc emerges as a next-generation engineering and manufacturing partner for the life science and diagnostics industry

ADLM 2025 studies highlight promising options for cervical and endometrial cancer

Forging a powerful partnership to accelerate global healthcare innovation and dominate the emerging AI-driven clinical decision support market

Key topics included the health effects of plastics, tackling medical misinformation, and advancing clinical care with AI